Company intelligence
Genentech
About Genentech
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or patientinfo@gene.com. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.
Verified activity
Signals from Genentech
24 published signals
Operations & Supply
Genentech officially reached a key construction milestone by topping out its new 700,000-square-foot biomanufacturing facility in Holly Springs, North Carolina.
Reported by Genentech
People
Genentech is recruiting for a contract role with a 3-6 month scope starting soon, ~30hr/week, with onsite in SSF requirements.
Reported by Shannon Adkins
Research & Knowledge
Genentech has worked for over two decades to better understand the biology behind vision loss, advancing research into VEGF-driven retinal diseases and exploring inflammation-mediated pathways such as IL-6.
Reported by Maria Isabel Arapa, MBA
Presence & Recognition
Genentech participated in the BIO 2026 conference to discuss how technology can improve lives and AI is influencing the future of healthcare.
Reported by Maria Isabel Arapa, MBA
People
Genentech hired Mengyao (Vivian) Zheng as a Manager, Therapeutic Area Analytics & Insights.
Reported by Mengyao (Vivian) Zheng
People
Genentech is hiring an EHS Leader to join the Site Leadership Team at its new state-of-the-art pharmaceutical manufacturing facility in Holly Springs, North Carolina.
Reported by Brett Gravois
Presence & Recognition
Genentech announced that Oakland Tech Week is centered on health equity and the legacy of free clinics established in Oakland to serve patients with sickle cell anemia.
Reported by Tiffany Renee Thomas
People
Genentech added Julia and Brayan to the board.
Reported by Tiffany Renee Thomas
Presence & Recognition
Genentech scientists are featured in the podcast Two Scientists Walk Into a Bar to learn more about emerging treatment approaches for inflammatory bowel disease.
Reported by Chris Melbourne
Presence & Recognition
Genentech is hosting a Global Legal Strategy Hub IP conference in Boston featuring a first portion on Trade Secrets and a second on Pharma and Biotech IP Litigation.
Reported by Damon Gupta
Presence & Recognition
Genentech participated in an inspiring 3-day event in Roche Brazil at the Compliance and Legal Pharma LATAM Summit.
Reported by Dara Pincas
Presence & Recognition
Genentech introduced Elizabeth, a runner living with relapsing-remitting MS, as part of the Hidden GeMS program to share her lived experience.
Reported by Maria Isabel Arapa, MBA
Products & Services
Genentech and Roche are redefining how treatments are developed and delivered to build a seamless continuum of care and transform patient outcomes globally.
Reported by Lac De Souza
Presence & Recognition
Genentech hosted a weekly Ask Nina B. question titled The Executive 'Dress Code'
Reported by Nina Blackshear, Esq., ACC, BCC
Presence & Recognition
Genentech participated in the BIO 2026 conference to discuss how AI is helping shape the future of biotechnology.
Reported by Chris Melbourne
Research & Knowledge
Genentech published Issue 63(5) September 2026 of Veterinary Pathology online.
Reported by Joshua Webster
Presence & Recognition
Genentech co-hosts Alecia and Luis in the podcast Two Scientists Walk into a Bar to discuss how scientists are building the lab of the future using AI and new technologies to execute experiments and analyze results more quickly.
Reported by Maria Isabel Arapa, MBA
People
Genentech hired Erin H. to start a new position in Holly Springs, North Carolina.
Reported by Erin H.
Presence & Recognition
Genentech hosted a hematology patient advocacy luncheon on campus to confront practical barriers between patients and care.
Reported by Genentech
Research & Knowledge
Genentech spent time with the Amazon team to discuss AI agents and context creation.
Reported by Davidek Herron, MBA
Presence & Recognition
Genentech hosted the Annual Marketing Summit where Nishit Doshi PhD met the CMO of OpenEvidence, a digital health success story.
Reported by Nishit Doshi PhD
Research & Knowledge
Genentech researchers published findings in Nature Biotechnology using a scoring system to rate gene importance in AI models analyzing single-cell RNA-sequencing data, uncovering gene patterns linked to diseases.
Reported by Maria Isabel Arapa, MBA
People
Genentech is hiring a Director of Planning, Warehouse, and Logistics to lead a team at the Roche Innovation Center Philadelphia (RICP) for a cGMP manufacturing facility making clinical and commercial gene therapy products.
Reported by Mary Palmer, MBA, PMP
Presence & Recognition
Genentech's Advancing Inclusive Research® (AIR) Site Alliance has successfully demonstrated that conducting representative research on a large scale is possible five years into the initiative.
Reported by Maria Isabel Arapa, MBA